Literature DB >> 15763175

Salsolinol induces a decrease in cyclic AMP at the median eminence and an increase at the adenohypophysis in lactating rats.

Balázs Radnai1, Zoltán Kandár, Anikó Somogyvári-Vigh, Zsuzsanna Mergl, Márk Oláh, Ferenc Fülöp, Miklós Vecsernyés, György M Nagy.   

Abstract

Investigating the cellular events in the pituitary gland, the intracellular cyclic AMP (cAMP) of the median eminence (ME), neuro-intermediate lobe (NIL) and the anterior lobe (AL) have been measured following 15-min of intravenous injection of salsolinol (SAL). Parallel to the elevation of plasma prolactin (PRL), SAL induced a significant decrease of cAMP concentration in the ME. In contrast, SAL injection resulted in a significant increase of cAMP at the level of the AL. Changes in cAMP of the NIL as well as in the plasma level of vasopressin (VP) could not be detected. The observed changes in the level of cAMP following the acute treatment of SAL in the ME and the AL seems to be related to interacting neuroendocrine signals delivered from the ME to the AL through the long portal vessels to release PRL.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15763175     DOI: 10.1016/j.brainresbull.2004.11.007

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  3 in total

Review 1.  Neurotoxins and neurotoxicity mechanisms. An overview.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

Review 2.  Role of salsolinol in the regulation of pituitary prolactin and peripheral dopamine release.

Authors:  Márk Oláh; Ibolya Bodnár; Galit Daniel; Béla E Tóth; Miklós Vecsernyés; György M Nagy
Journal:  Reprod Med Biol       Date:  2011-05-03

Review 3.  Salsolinol: an Unintelligible and Double-Faced Molecule-Lessons Learned from In Vivo and In Vitro Experiments.

Authors:  Magdalena Kurnik-Łucka; Pertti Panula; Andrzej Bugajski; Krzysztof Gil
Journal:  Neurotox Res       Date:  2017-10-23       Impact factor: 3.911

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.